DSG Capital Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
DSG Capital Advisors's ABBV Position: Q3 2026 in Review
DSG Capital Advisors reduced its AbbVie (ABBV) stake by 4.1% in Q3 2026, selling an estimated $225K and leaving 20,584 shares worth $5.38M. The position accounts for 0.77% of the portfolio, ranked #32.
DSG Capital Advisors first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. The position peaked at $9.8M in Q4 2025. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- DSG Capital Advisors held 20,584 shares of AbbVie worth $5.38M as of Q3 2026.
- DSG Capital Advisors sold 876 AbbVie shares in Q3 2026, an estimated $225K.
- AbbVie made up 0.77% of DSG Capital Advisors's portfolio in Q3 2026, its #32 holding.
- DSG Capital Advisors first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
- DSG Capital Advisors's AbbVie position peaked at $9.8M in Q4 2025.
- 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on DSG Capital Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.